US Physical Therapy/$USPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About US Physical Therapy
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Ticker
$USPH
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
5,531
ISIN
US90337L1089
Website
USPH Metrics
BasicAdvanced
$1.2B
36.19
$2.17
1.44
$1.78
2.29%
Price and volume
Market cap
$1.2B
Beta
1.44
52-week high
$100.84
52-week low
$62.77
Average daily volume
169K
Dividend rate
$1.78
Financial strength
Current ratio
1.174
Quick ratio
1.063
Long term debt to equity
33.982
Total debt to equity
40.488
Dividend payout ratio (TTM)
79.75%
Interest coverage (TTM)
8.48%
Profitability
EBITDA (TTM)
91.058
Gross margin (TTM)
21.75%
Net profit margin (TTM)
4.81%
Operating margin (TTM)
10.20%
Effective tax rate (TTM)
24.42%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
4.02%
Return on equity (TTM)
6.63%
Valuation
Price to earnings (TTM)
36.194
Price to revenue (TTM)
1.715
Price to book
2.4
Price to tangible book (TTM)
-3.37
Price to free cash flow (TTM)
21.239
Free cash flow yield (TTM)
4.71%
Free cash flow per share (TTM)
370.50%
Dividend yield (TTM)
2.26%
Forward dividend yield
2.29%
Growth
Revenue change (TTM)
14.31%
Earnings per share change (TTM)
81.25%
3-year revenue growth (CAGR)
10.80%
10-year revenue growth (CAGR)
8.42%
3-year earnings per share growth (CAGR)
-8.83%
10-year earnings per share growth (CAGR)
3.07%
3-year dividend per share growth (CAGR)
5.21%
10-year dividend per share growth (CAGR)
13.25%
What the Analysts think about USPH
Analyst ratings (Buy, Hold, Sell) for US Physical Therapy stock.
Bulls say / Bears say
U.S. Physical Therapy reported a 12.02% revenue growth as of September 30, 2024, indicating strong demand for its services. (benzinga.com)
Analysts have maintained a 'Buy' rating for U.S. Physical Therapy, citing consistent record-setting patient traffic and effective cost management. (markets.businessinsider.com)
The company's net margin of 3.46% surpasses industry benchmarks, reflecting efficient cost management and strong financial health. (benzinga.com)
Barrington Research lowered its price target for U.S. Physical Therapy from $108 to $98, indicating potential concerns about future performance. (defenseworld.net)
The company's debt-to-equity ratio of 0.53, while below industry average, suggests a reliance on debt financing that could pose risks if not managed properly. (benzinga.com)
Insider selling activity, such as CFO Carey P. Hendrickson's sale of 516 shares, may signal potential concerns about the company's future prospects. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 10 Jun 2025.
USPH Financial Performance
Revenues and expenses
USPH Earnings Performance
Company profitability
USPH News
AllArticlesVideos
U.S. Physical Therapy Presented at Investor Conferences
Business Wire·2 weeks ago
U.S. Physical Therapy Announces Dual Listing on NYSE Texas
Business Wire·4 weeks ago
U.S. Physical Therapy Clinics Market Analysis 2025: $53 Billion Industry Primed for Consolidation - M&A Activity Surges in Fragmented Therapy Sector
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for US Physical Therapy stock?
US Physical Therapy (USPH) has a market cap of $1.2B as of June 27, 2025.
What is the P/E ratio for US Physical Therapy stock?
The price to earnings (P/E) ratio for US Physical Therapy (USPH) stock is 36.19 as of June 27, 2025.
Does US Physical Therapy stock pay dividends?
Yes, the US Physical Therapy (USPH) stock pays dividends to shareholders. As of June 27, 2025, the dividend rate is $1.78 and the yield is 2.29%. US Physical Therapy has a payout ratio of 79.75% on a trailing twelve-month basis.
When is the next US Physical Therapy dividend payment date?
The next US Physical Therapy (USPH) dividend payment date is unconfirmed.
What is the beta indicator for US Physical Therapy?
US Physical Therapy (USPH) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.